cephalosporin c has been researched along with sisomicin in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 14 (70.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (10.00) | 24.3611 |
2020's | 4 (20.00) | 2.80 |
Authors | Studies |
---|---|
Kohl, S; Pickering, LK | 1 |
Simon, C | 1 |
Flournoy, DJ | 1 |
Bentfeld, G; Schassan, HH | 1 |
McAllister, TA | 1 |
Friedrich, H; Hänsel-Friedrich, G; Pelz, K | 1 |
Clavijo, E; García Luque, IG; Nogales, MC; Perea, EJ | 1 |
Nishino, T; Saito, M; Shibata, K; Tanino, T | 1 |
Aznar, J; Iglesias, MC; Martin, E; Nogales, MC; Perea, EJ | 1 |
Azuma, K; Nishino, T; Saito, M; Tanino, T | 1 |
Ikeda, C; Tachibana, A; Yano, K | 2 |
Lirussi, F; Martines, D; Nassuato, G; Okolicsanyi, L; Orlando, R; Venuti, M | 1 |
Ciammaichella, A | 1 |
Appelbaum, PC; Ednie, LM; Lin, G | 1 |
Kidd, JM; Kuti, JL; Nicolau, DP | 1 |
Bassetti, M; Battaglini, D; Giacobbe, DR; Pelosi, P; Vena, A | 1 |
Clabots, C; Johnson, JR; Johnston, BD; Porter, SB; Thuras, P | 1 |
Garcia, JA; Liang, SY; Long, B; Matlock, A; Moussavi, K | 1 |
Pregnolato, M; Taccani, M; Terreni, M | 1 |
6 review(s) available for cephalosporin c and sisomicin
Article | Year |
---|---|
Recent advances in antimicrobial therapy.
Topics: Amikacin; Amoxicillin; Anti-Bacterial Agents; Cephalosporins; Clindamycin; Humans; Metronidazole; Sisomicin; Spectinomycin; Sulfamethoxazole; Ticarcillin; Tobramycin; Trimethoprim | 1977 |
Recent advances in antibiotics.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Antitubercular Agents; Bacteria; Bacterial Infections; Cephalosporins; Cephamycins; Flucytosine; Gentamicins; Metronidazole; Penicillins; Plasmids; Sisomicin; Tobramycin | 1976 |
Novel pharmacotherapy for the treatment of hospital-acquired and ventilator-associated pneumonia caused by resistant gram-negative bacteria.
Topics: Administration, Inhalation; Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Clinical Trials as Topic; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Humans; Pneumonia, Ventilator-Associated; Sisomicin | 2018 |
The role of new antimicrobials for Gram-negative infections in daily clinical practice.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azabicyclo Compounds; beta-Lactams; Carbapenems; Cefiderocol; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem; Microbial Sensitivity Tests; Polymyxins; Sisomicin; Tazobactam; Tetracyclines | 2020 |
Advances in novel antibiotics to treat multidrug-resistant gram-negative bacterial infections.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Boronic Acids; Cefiderocol; Ceftazidime; Cephalosporins; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Design; Drug Resistance, Multiple; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Heterocyclic Compounds, 1-Ring; Humans; Meropenem; Sisomicin; Tazobactam; Tetracyclines | 2021 |
New Antibiotics for Multidrug-Resistant Bacterial Strains: Latest Research Developments and Future Perspectives.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Boronic Acids; Cefiderocol; Cephalosporins; Chemistry, Pharmaceutical; Clostridioides difficile; Clostridium Infections; Drug Design; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gonorrhea; Humans; Meropenem; Neisseria gonorrhoeae; Nitroimidazoles; Sisomicin; Tetracyclines | 2021 |
14 other study(ies) available for cephalosporin c and sisomicin
Article | Year |
---|---|
[Possible indications for recently developed antibiotics [author's transl)].
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Cephalosporins; Kinetics; Netilmicin; Penicillins; Sisomicin | 1979 |
Netilmicin synergy with carbenicillin or cefamandole against Serratia.
Topics: Carbenicillin; Cefamandole; Cephalosporins; Drug Synergism; Gentamicins; Microbial Sensitivity Tests; Serratia; Sisomicin | 1978 |
[Microbiological evaluation of cefoxitin, a new beta-lactamase resistant cephamycin antibiotic, compared to cephalothin, cephaloridine and cefazolin].
Topics: Cefazolin; Cefoxitin; Cephaloridine; Cephalosporinase; Cephalosporins; Cephalothin; Drug Combinations; Drug Resistance, Microbial; Gentamicins; Sisomicin | 1978 |
[Investigation of the c. s. fluid levels of two newer antibiotics; cefazolin and sisomicin (author's transl)].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Cefazolin; Cephalosporins; Child; Child, Preschool; Gentamicins; Humans; Middle Aged; Sisomicin | 1977 |
Interaction of aminoglycosides and cephalosporins against Pseudomonas aeruginosa. Correlation between interaction index and killing curve.
Topics: Amikacin; Anti-Bacterial Agents; Cefotaxime; Ceftazidime; Cephalosporins; Culture Media; Drug Resistance, Microbial; Drug Synergism; Gentamicins; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Sisomicin | 1988 |
[Studies on the combination action of sisomicin, gentamicin and piperacillin, cefmetazole against Pseudomonas aeruginosa and Serratia marcescens].
Topics: Animals; Cefmetazole; Cephalosporins; Cephamycins; Drug Evaluation, Preclinical; Drug Synergism; Gentamicins; Male; Mice; Penicillin Resistance; Penicillins; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Serratia marcescens; Sisomicin | 1983 |
Synergy between cefotaxime, cefsulodin, azlocillin, mezlocillin and aminoglycosides against carbenicillin resistant or sensitive Pseudomonas aeruginosa.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Carbenicillin; Cefotaxime; Cefsulodin; Cephalosporins; Dibekacin; Drug Synergism; Gentamicins; Mezlocillin; Penicillin Resistance; Penicillins; Pseudomonas aeruginosa; Sisomicin; Tobramycin | 1980 |
[Combination action of sisomicin, dibekacin and cefotetan, cefotaxime, latamoxef, and cefsulodin against Escherichia coli, Serratia marcescens, and Pseudomonas aeruginosa].
Topics: Anti-Bacterial Agents; Cefotaxime; Cefotetan; Cefsulodin; Cephalosporins; Cephamycins; Dibekacin; Drug Resistance, Microbial; Drug Synergism; Escherichia coli; Kanamycin; Moxalactam; Pseudomonas aeruginosa; Serratia marcescens; Sisomicin | 1983 |
[Pharmacokinetics of cefotetan and an aminoglycoside preparation in combined administration. 1. Individual quantification of cefotetan and sisomicin by bioassay and their absorption, distribution, and excretion in rats when given together].
Topics: Absorption; Animals; Anti-Bacterial Agents; Biological Assay; Cefotetan; Cephalosporins; Cephamycins; Gentamicins; Injections, Intramuscular; Injections, Intravenous; Kidney; Kinetics; Liver; Male; Rats; Rats, Inbred Strains; Sisomicin | 1982 |
[Pharmacokinetics of a cefotetan and an aminoglycoside preparation in combined administration. 2. Absorption and exercise of cefotetan and sisomicin in dogs when the two are given together].
Topics: Absorption; Animals; Anti-Bacterial Agents; Cefotetan; Cephalosporins; Cephamycins; Dogs; Female; Gentamicins; Injections, Intramuscular; Injections, Intravenous; Kinetics; Sisomicin | 1982 |
[Therapeutic effectiveness of metossimine associated with an aminoglycoside in a case of severe gram-negative sepsis].
Topics: Cefuroxime; Cephalosporins; Diabetes Complications; Drug Therapy, Combination; Escherichia coli Infections; Gastrointestinal Diseases; Gentamicins; Humans; Male; Middle Aged; Paromomycin; Proteus Infections; Sisomicin | 1981 |
[Medical and therapeutic aspects of hospital infections].
Topics: Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Cephradine; Cross Infection; Drug Resistance, Microbial; Gentamicins; Humans; Sisomicin | 1980 |
Antistaphylococcal activity of ACHN-490 tested alone and in combination with other agents by time-kill assay.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Daptomycin; Drug Resistance, Bacterial; Drug Synergism; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Sisomicin; Time Factors | 2010 |
Comparative activity of plazomicin against extended-spectrum cephalosporin-resistant Escherichia coli clinical isolates (2012-2017) in relation to phylogenetic background, sequence type 131 subclones, bla
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Genotype; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Phylogeny; Sisomicin; Young Adult | 2021 |